RAPID: Viral structure-function-activity in the engineered wastewater cycle

RAPID:工程废水循环中的病毒结构-功能-活性

基本信息

  • 批准号:
    2026599
  • 负责人:
  • 金额:
    $ 19.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-05-01 至 2022-12-31
  • 项目状态:
    已结题

项目摘要

The current global COVID-19 pandemic is caused by SARS-CoV2, a coronavirus. While human coronaviruses are highly infective and responsible for the majority of respiratory tract infections, the novel SARS-CoV2 is particularly virulent. These viruses can survive under a variety of conditions and environments including within human waste streams. Wastewater treatment systems are widely used as a final barrier to protect water bodies from the impacts of human pollution. However, the fate of coronaviruses during the wastewater treatment process is poorly understood. The goal of this RAPID project is to develop a science-based understanding of the fate of SARS-CoV2 and other viruses during the treatment of human waste in wastewater treatment plants. Results of this research will inform the scientific community and relevant stakeholders of the impact of waste treatment on SARS-CoV2, as well as other potential threats and agents. If successful, this approach will provide urgently needed information to help respond to the current global pandemic and form the basis of a global database for future pandemic events. This proposal addresses a current pressing need to understand the abundance, activity and transmission of SARS-CoV2 and other viral determinants in engineered wastewater treatment systems. The emergence of increasingly frequent and especially potent microbial pathogens like SARS-CoV2 presents an urgent challenge to public health. The extremely rapid global spread of SARS-CoV-2 infections as well as an asymptomatic latency period in subjects suggests significant gaps in our understanding of potential reservoirs and transmission pathways of SARS-CoV2. One such reservoir and potential transmission pathway is the engineered wastewater cycle. Wastewater treatment serves to reduce pollution and minimize exposure of human populations to microbiological threats. The goal of this project is to determine if wastewater treatment systems serve as a reservoir in the current COVID-19 pandemic. This will be achieved by conducting a worldwide environmental surveillance study using massively parallel high-throughput systems biology approaches to characterize viral structure-function-activity measures in the engineered wastewater cycle. The results of this study will provide a database of SARS-CoV2 and other viruses in a broad spectrum of waste streams, treatment systems, and disinfection processes. A second aim of this research is to develop -omics based biomarkers and quantitative assays for SARS-CoV2 to track fate in engineered wastewater treatment systems. Successful completion of this research will provide urgently needed information on SARS-CoV2 behavior in the environment that will inform efforts to manage and mitigate the impacts of the global pandemic.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
当前的全球COVID-19大流行是由冠状病毒SARS-CoV2引起的。虽然人类冠状病毒具有高度传染性,是大多数呼吸道感染的罪魁祸首,但新型SARS-CoV2的毒性特别强。这些病毒可以在各种条件和环境下生存,包括在人类废物流中。废水处理系统被广泛用作保护水体免受人类污染影响的最后屏障。然而,人们对冠状病毒在废水处理过程中的命运知之甚少。该RAPID项目的目标是在污水处理厂处理人类废物期间,对SARS-CoV2和其他病毒的命运建立基于科学的认识。这项研究的结果将使科学界和相关利益攸关方了解废物处理对SARS-CoV2以及其他潜在威胁和病原体的影响。如果取得成功,这一方法将提供急需的信息,以帮助应对当前的全球大流行病,并为今后的大流行病事件建立全球数据库。该提案解决了当前迫切需要了解工程废水处理系统中SARS-CoV2和其他病毒决定因素的丰度、活性和传播。SARS-CoV2等日益频繁和特别强效的微生物病原体的出现对公共卫生构成了紧迫的挑战。SARS-CoV-2感染在全球的迅速传播以及受试者的无症状潜伏期表明,我们对SARS-CoV-2的潜在宿主和传播途径的理解存在重大差距。其中一个蓄水池和潜在的传播途径是工程废水循环。废水处理有助于减少污染,并尽量减少人类对微生物威胁的暴露。该项目的目标是确定废水处理系统是否在当前的COVID-19大流行中起到蓄水池的作用。这将通过开展一项全球环境监测研究来实现,该研究使用大规模并行的高通量系统生物学方法来表征工程废水循环中的病毒结构-功能-活性措施。这项研究的结果将提供一个广泛的废物流、处理系统和消毒过程中SARS-CoV2和其他病毒的数据库。这项研究的第二个目标是为SARS-CoV2开发基于组学的生物标志物和定量分析,以跟踪工程废水处理系统中的命运。这项研究的成功完成将提供关于SARS-CoV2在环境中的行为的迫切需要的信息,这将为管理和减轻全球大流行影响的努力提供信息。该奖项反映了美国国家科学基金会的法定使命,并通过使用基金会的知识价值和更广泛的影响审查标准进行评估,被认为值得支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kartik Chandran其他文献

Projections of wastewater as an indicator of COVID-19 cases in corrections facilities: a modelling study
废水预测作为惩教设施中 COVID-19 病例的指标:建模研究
Aerobic thermophilic digestion of fecal matter: Condensate recovery, low solids production, and water reuse
  • DOI:
    10.1016/j.biteb.2024.102008
  • 发表时间:
    2024-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Ruby A. Lai;Sung-Geun Woo;Emir Aksüyek;Latifah Hamzah;Santiago Alvillar;Kartik Chandran;Craig S. Criddle
  • 通讯作者:
    Craig S. Criddle
Activity, abundance, and identification of N2O-reducing bacteria present in Anammox biomass - Combination of 15N tracer and molecular analyses
Anammox 生物质中存在的 N2O 还原细菌的活性、丰度和鉴定 - 15N 示踪剂和分子分析相结合
  • DOI:
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Toshikazu Suenaga;Takumi Ota;Tomoyuki Hori;Shohei Riya;2;Masaaki Hosomi;Kartik Chandran;Susanne Lackner;Barth F. Smets;Akihiko Terada
  • 通讯作者:
    Akihiko Terada
2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales
  • DOI:
    10.1007/s00705-020-04731-2
  • 发表时间:
    2020-09-04
  • 期刊:
  • 影响因子:
    2.500
  • 作者:
    Jens H. Kuhn;Scott Adkins;Daniela Alioto;Sergey V. Alkhovsky;Gaya K. Amarasinghe;Simon J. Anthony;Tatjana Avšič-Županc;María A. Ayllón;Justin Bahl;Anne Balkema-Buschmann;Matthew J. Ballinger;Tomáš Bartonička;Christopher Basler;Sina Bavari;Martin Beer;Dennis A. Bente;Éric Bergeron;Brian H. Bird;Carol Blair;Kim R. Blasdell;Steven B. Bradfute;Rachel Breyta;Thomas Briese;Paul A. Brown;Ursula J. Buchholz;Michael J. Buchmeier;Alexander Bukreyev;Felicity Burt;Nihal Buzkan;Charles H. Calisher;Mengji Cao;Inmaculada Casas;John Chamberlain;Kartik Chandran;Rémi N. Charrel;Biao Chen;Michela Chiumenti;Il-Ryong Choi;J. Christopher S. Clegg;Ian Crozier;John V. da Graça;Elena Dal Bó;Alberto M. R. Dávila;Juan Carlos de la Torre;Xavier de Lamballerie;Rik L. de Swart;Patrick L. Di Bello;Nicholas Di Paola;Francesco Di Serio;Ralf G. Dietzgen;Michele Digiaro;Valerian V. Dolja;Olga Dolnik;Michael A. Drebot;Jan Felix Drexler;Ralf Dürrwald;Lucie Dufkova;William G. Dundon;W. Paul Duprex;John M. Dye;Andrew J. Easton;Hideki Ebihara;Toufic Elbeaino;Koray Ergünay;Jorlan Fernandes;Anthony R. Fooks;Pierre B. H. Formenty;Leonie F. Forth;Ron A. M. Fouchier;Juliana Freitas-Astúa;Selma Gago-Zachert;George Fú Gāo;María Laura García;Adolfo García-Sastre;Aura R. Garrison;Aiah Gbakima;Tracey Goldstein;Jean-Paul J. Gonzalez;Anthony Griffiths;Martin H. Groschup;Stephan Günther;Alexandro Guterres;Roy A. Hall;John Hammond;Mohamed Hassan;Jussi Hepojoki;Satu Hepojoki;Udo Hetzel;Roger Hewson;Bernd Hoffmann;Seiji Hongo;Dirk Höper;Masayuki Horie;Holly R. Hughes;Timothy H. Hyndman;Amara Jambai;Rodrigo Jardim;Dàohóng Jiāng;Qi Jin;Gilda B. Jonson;Sandra Junglen;Serpil Karadağ;Karen E. Keller;Boris Klempa;Jonas Klingström;Gary Kobinger;Hideki Kondō;Eugene V. Koonin;Mart Krupovic;Gael Kurath;Ivan V. Kuzmin;Lies Laenen;Robert A. Lamb;Amy J. Lambert;Stanley L. Langevin;Benhur Lee;Elba R. S. Lemos;Eric M. Leroy;Dexin Li;Jiànróng Lǐ;Mifang Liang;Wénwén Liú;Yàn Liú;Igor S. Lukashevich;Piet Maes;William Marciel de Souza;Marco Marklewitz;Sergio H. Marshall;Giovanni P. Martelli;Robert R. Martin;Shin-Yi L. Marzano;Sébastien Massart;John W. McCauley;Nicole Mielke-Ehret;Angelantonio Minafra;Maria Minutolo;Ali Mirazimi;Hans-Peter Mühlbach;Elke Mühlberger;Rayapati Naidu;Tomohide Natsuaki;Beatriz Navarro;José A. Navarro;Sergey V. Netesov;Gabriele Neumann;Norbert Nowotny;Márcio R. T. Nunes;Are Nylund;Arnfinn L. Økland;Renata C. Oliveira;Gustavo Palacios;Vicente Pallas;Bernadett Pályi;Anna Papa;Colin R. Parrish;Alex Pauvolid-Corrêa;Janusz T. Pawęska;Susan Payne;Daniel R. Pérez;Florian Pfaff;Sheli R. Radoshitzky;Aziz-ul Rahman;Pedro L. Ramos-González;Renato O. Resende;Carina A. Reyes;Bertus K. Rima;Víctor Romanowski;Gabriel Robles Luna;Paul Rota;Dennis Rubbenstroth;Jonathan A. Runstadler;Daniel Ruzek;Sead Sabanadzovic;Jiří Salát;Amadou Alpha Sall;Maria S. Salvato;Kamil Sarpkaya;Takahide Sasaya;Martin Schwemmle;Muhammad Z. Shabbir;Xiǎohóng Shí;Zhènglì Shí;Yukio Shirako;Peter Simmonds;Jana Širmarová;Manuela Sironi;Sophie Smither;Teemu Smura;Jin-Won Song;Kirsten M. Spann;Jessica R. Spengler;Mark D. Stenglein;David M. Stone;Petra Straková;Ayato Takada;Robert B. Tesh;Natalie J. Thornburg;Keizō Tomonaga;Noël Tordo;Jonathan S. Towner;Massimo Turina;Ioannis Tzanetakis;Rainer G. Ulrich;Anna Maria Vaira;Bernadette van den Hoogen;Arvind Varsani;Nikos Vasilakis;Martin Verbeek;Victoria Wahl;Peter J. Walker;Hui Wang;Jianwei Wang;Xifeng Wang;Lin-Fa Wang;Tàiyún Wèi;Heather Wells;Anna E. Whitfield;John V. Williams;Yuri I. Wolf;Zhìqiáng Wú;Xin Yang;Xīnglóu Yáng;Xuejie Yu;Natalya Yutin;F. Murilo Zerbini;Tong Zhang;Yong-Zhen Zhang;Guohui Zhou;Xueping Zhou
  • 通讯作者:
    Xueping Zhou
Microbial response on the first full-scale DEMON® biomass transfer for mainstream deammonification
  • DOI:
    10.1016/j.watres.2022.118517
  • 发表时间:
    2022-06-30
  • 期刊:
  • 影响因子:
  • 作者:
    Sabine Marie Podmirseg;María Gómez-Brandón;Markus Muik;Blaz Stres;Martin Hell;Thomas Pümpel;Sudhir Murthy;Kartik Chandran;Hongkeun Park;Heribert Insam;Bernhard Wett
  • 通讯作者:
    Bernhard Wett

Kartik Chandran的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kartik Chandran', 18)}}的其他基金

GOALI: Omics- and metabolically-informed out-selection of Nitrospira spp. and Comammox bacteria from energy efficient engineered nitrogen removal processes
目标:Nitrospira spp 的组学和代谢信息淘汰选择。
  • 批准号:
    1706726
  • 财政年份:
    2017
  • 资助金额:
    $ 19.84万
  • 项目类别:
    Standard Grant
Proposal to Support the International Water Association Resource Recovery Conference IRRC 2017, Linking Global Challenges, August 7th- 9th, 2017 | New York, NY
支持国际水协会资源回收会议 IRRC 2017 的提案,链接全球挑战,2017 年 8 月 7 日至 9 日 |
  • 批准号:
    1715497
  • 财政年份:
    2017
  • 资助金额:
    $ 19.84万
  • 项目类别:
    Standard Grant
Collaborative Research: Probing Active Fraction and Metabolic Function to Elucidate Mechanisms of Pharmaceutical Biotransformations during Nitrification-Denitrification
合作研究:探索活性组分和代谢功能以阐明硝化反硝化过程中药物生物转化的机制
  • 批准号:
    1438578
  • 财政年份:
    2014
  • 资助金额:
    $ 19.84万
  • 项目类别:
    Standard Grant
Travel Grant Proposal to Support Participation of US Researchers at the International Water Association Workshop, Global Challenges:Sustainable Wastewater Treatment and Resource
支持美国研究人员参加国际水协会研讨会“全球挑战:可持续废水处理和资源”的旅费资助提案
  • 批准号:
    1441476
  • 财政年份:
    2014
  • 资助金额:
    $ 19.84万
  • 项目类别:
    Standard Grant
I-Corps: Development of the Next Generation Wastewater Treatment Technologies and Infrastructure
I-Corps:下一代废水处理技术和基础设施的开发
  • 批准号:
    1261062
  • 财政年份:
    2012
  • 资助金额:
    $ 19.84万
  • 项目类别:
    Standard Grant
Biological conversion of methane to methanol using monooxygenic pathways in autotrophic ammonia oxidizing bacteria
利用自养氨氧化细菌中的单产氧途径将甲烷生物转化为甲醇
  • 批准号:
    1236297
  • 财政年份:
    2012
  • 资助金额:
    $ 19.84万
  • 项目类别:
    Standard Grant
GOALI: Strategies for Design, Startup and Control of Field-Scale Anammox Reactors
GOALI:现场规模厌氧氨氧化反应器的设计、启动和控制策略
  • 批准号:
    1066860
  • 财政年份:
    2011
  • 资助金额:
    $ 19.84万
  • 项目类别:
    Standard Grant
EAGER: Feasibility Study of Micro-Level Sensing and Process Control of Nitrification
EAGER:硝化微观传感和过程控制的可行性研究
  • 批准号:
    1025685
  • 财政年份:
    2010
  • 资助金额:
    $ 19.84万
  • 项目类别:
    Standard Grant
RAPID: ACQUISITION OF A PROTEOMICS ANALYZER TO ELUCIDATE PATHWAYS OF PETROLEUM HYDROCARBON BIOREMEDIATION IN THE GULF OF MEXICO
RAPID:购买蛋白质组分析仪来阐明墨西哥湾石油碳氢化合物生物修复的途径
  • 批准号:
    1057414
  • 财政年份:
    2010
  • 资助金额:
    $ 19.84万
  • 项目类别:
    Standard Grant
CAREER: Molecular mechanisms and metabolic modeling of N2O and NO emission fluxes from biological nitrogen removal reactors
职业:生物脱氮反应器 N2O 和 NO 排放通量的分子机制和代谢模型
  • 批准号:
    0846650
  • 财政年份:
    2009
  • 资助金额:
    $ 19.84万
  • 项目类别:
    Standard Grant

相似国自然基金

大豆MYB(v-myb avian myeloblastosis viral oncogene homolog)转录因子基因对大豆异黄酮合成调控的研究
  • 批准号:
    31371641
  • 批准年份:
    2013
  • 资助金额:
    15.0 万元
  • 项目类别:
    面上项目

相似海外基金

Developing Novel Trans-Synaptic Viral Vectors for Orthogonal or Rapid Circuit Tracing
开发用于正交或快速电路追踪的新型跨突触病毒载体
  • 批准号:
    10640622
  • 财政年份:
    2023
  • 资助金额:
    $ 19.84万
  • 项目类别:
Rapid disease progression and viral reservoir formation in SIV-infected infant macaques
感染 SIV 的幼年猕猴的疾病快速进展和病毒库形成
  • 批准号:
    10330882
  • 财政年份:
    2021
  • 资助金额:
    $ 19.84万
  • 项目类别:
Rapid disease progression and viral reservoir formation in SIV-infected infant macaques
感染 SIV 的幼年猕猴的疾病快速进展和病毒库形成
  • 批准号:
    10428674
  • 财政年份:
    2021
  • 资助金额:
    $ 19.84万
  • 项目类别:
Rapid disease progression and viral reservoir formation in SIV-infected infant macaques
感染 SIV 的幼年猕猴的疾病快速进展和病毒库形成
  • 批准号:
    10640931
  • 财政年份:
    2021
  • 资助金额:
    $ 19.84万
  • 项目类别:
design and rapid production of a drug-screening target from the highly conserved HR1 region of the viral spike protein (S2)
从病毒刺突蛋白 (S2) 高度保守的 HR1 区域设计并快速生产药物筛选靶点
  • 批准号:
    10221150
  • 财政年份:
    2020
  • 资助金额:
    $ 19.84万
  • 项目类别:
Barcoded Magnetic Beads for Rapid Tests of MRSA and Respiratory Viral Panels
用于快速检测 MRSA 和呼吸道病毒检测的条形码磁珠
  • 批准号:
    7926790
  • 财政年份:
    2010
  • 资助金额:
    $ 19.84万
  • 项目类别:
Synthetic Viral Genome Design for Rapid Vaccine Development
用于快速疫苗开发的合成病毒基因组设计
  • 批准号:
    8048029
  • 财政年份:
    2008
  • 资助金额:
    $ 19.84万
  • 项目类别:
Synthetic Viral Genome Design for Rapid Vaccine Development
用于快速疫苗开发的合成病毒基因组设计
  • 批准号:
    8238127
  • 财政年份:
    2008
  • 资助金额:
    $ 19.84万
  • 项目类别:
Synthetic Viral Genome Design for Rapid Vaccine Development
用于快速疫苗开发的合成病毒基因组设计
  • 批准号:
    7591176
  • 财政年份:
    2008
  • 资助金额:
    $ 19.84万
  • 项目类别:
Synthetic Viral Genome Design for Rapid Vaccine Development
用于快速疫苗开发的合成病毒基因组设计
  • 批准号:
    7780320
  • 财政年份:
    2008
  • 资助金额:
    $ 19.84万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了